POMALYSTREMS.COM: Keyword Density Checker

Total words: 756 | 2-word phrases: 196 | 3-word phrases: 215 | 4-word phrases: 222

PAGE INFO

Title	Try to keep the title under 60 characters (52 characters) Welcome to the POMALYST REMS program - Pomalyst REMS
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (36 characters) Welcome to the POMALYST REMS program

#	Keyword	Frequency	Density
1	the pomalyst rems	5	2.33%
2	pomalyst rems program	4	1.86%
3	additional information about	2	0.93%
4	and mitigation strategy	2	0.93%
5	evaluation and mitigation	2	0.93%
6	center at 18884235436	2	0.93%
7	call center at	2	0.93%
8	rems call center	2	0.93%
9	the rems call	2	0.93%
10	program please contact	2	0.93%
11	rems program please	2	0.93%
12	about the pomalyst	2	0.93%
13	information about the	2	0.93%
14	welcome to the	2	0.93%
15	to the pomalyst	2	0.93%
16	all the conditions	1	0.47%
17	patients and pharmacists	1	0.47%
18	risk of embryofetal	1	0.47%
19	of embryofetal exposure	1	0.47%
20	embryofetal exposure to	1	0.47%
21	exposure to pomalyst	1	0.47%
22	to pomalyst to	1	0.47%
23	pomalyst to inform	1	0.47%
24	prescribers patients and	1	0.47%
25	pharmacists on the	1	0.47%
26	and pharmacists on	1	0.47%
27	prescribe and dispense	1	0.47%
28	on the serious	1	0.47%
29	can prescribe and	1	0.47%
30	the serious risks	1	0.47%

#	Keyword	Frequency	Density
1	the pomalyst rems program	4	1.80%
2	welcome to the pomalyst	2	0.90%
3	evaluation and mitigation strategy	2	0.90%
4	call center at 18884235436	2	0.90%
5	rems call center at	2	0.90%
6	the rems call center	2	0.90%
7	rems program please contact	2	0.90%
8	information about the pomalyst	2	0.90%
9	additional information about the	2	0.90%
10	to the pomalyst rems	2	0.90%
11	risk of embryofetal exposure	1	0.45%
12	strategy are as follows	1	0.45%
13	prescribers and pharmacies certified	1	0.45%
14	only prescribers and pharmacies	1	0.45%
15	program called “pomalyst rems”	1	0.45%
16	are as follows to	1	0.45%
17	prevent the risk of	1	0.45%
18	the risk of embryofetal	1	0.45%
19	of embryofetal exposure to	1	0.45%
20	and mitigation strategy are	1	0.45%
21	embryofetal exposure to pomalyst	1	0.45%
22	exposure to pomalyst to	1	0.45%
23	to pomalyst to inform	1	0.45%
24	prescribers patients and pharmacists	1	0.45%
25	patients and pharmacists on	1	0.45%
26	and pharmacists on the	1	0.45%
27	pharmacists on the serious	1	0.45%
28	on the serious risks	1	0.45%
29	mitigation strategy are as	1	0.45%
30	and pharmacies certified by	1	0.45%
31	can prescribe and dispense	1	0.45%
32	all the conditions of	1	0.45%
33	prescribe and dispense pomalyst	1	0.45%
34	and dispense pomalyst to	1	0.45%
35	dispense pomalyst to patients	1	0.45%
36	pomalyst to patients who	1	0.45%
37	to patients who are	1	0.45%
38	patients who are enrolled	1	0.45%
39	who are enrolled and	1	0.45%
40	meet all the conditions	1	0.45%

#	URL	Whois	Check
1	https://packageinserts.bms.com/pi/pi_pomalyst.pdf	Whois	bms.com
2	https://packageinserts.bms.com/medguide/medguide_pomalyst.pdf	Whois	bms.com
3	https://www.bms.com/privacy-policy.html	Whois	bms.com
4	https://www.bms.com/legal-notice.html	Whois	bms.com
5	https://www.bms.com/about-us/contact-us.html	Whois	bms.com
6	https://www.bms.com/	Whois	bms.com